Overview

* Nuwellis ( NUWE ) Q3 revenue fell 6% yr/yr but rose 29% sequentially

* Net income for Q3 was $468,000, with EPS of $0.56

* Company initiated manufacturing transition to focus on U.S. market growth

Outlook

* Nuwellis ( NUWE ) focuses on U.S. market growth, exiting international operations

* Company enhances product offerings with new 24-hour circuit and catheter

* Nuwellis ( NUWE ) advances pediatric product development with NIH-funded collaboration

Result Drivers

* CONSUMABLE UTILIZATION - Sequential revenue growth driven by increased consumable utilization and stronger U.S. console sales

* PEDIATRIC PRODUCT DEVELOPMENT - Accelerated through NIH-funded collaboration and new U.S. patent

* U.S. MARKET FOCUS - Manufacturing transition to KDI Precision Manufacturing and exit of international operations

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Sales $2.22

mln

Q3 EPS $0.56

Q3 Net $468,000

Income

Q3 Gross $1.45

Profit mln

Q3 -$2.70

Income mln

from

Operatio

ns

Q3 $468,000

Pretax

Profit

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)